PAR
Click for more information
8.33% 26.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-3

  1. Hotpy
    60 Posts.
    lightbulb Created with Sketch. 30
    clock Created with Sketch.
    09/02/24
    09:16
    Post #: 72317224
    I can't see anything very standout in here, no improvement in GAGS. maybe someone else with more knowledge than me sees more?? please.....
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢ 		Change
0.020(8.33%) 		Mkt cap ! $90.94M
Open High Low Value Volume
24.5¢ 26.0¢ 24.5¢ $195.9K 781.9K

Buyers (Bids)

No. Vol. Price($)
2 38000 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 102892 9
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.